The Sequence Dependence of Cell Growth Inhibition by EGFR-Tyrosine Kinase Inhibitor ZD1839, Docetaxel and Cisplatin in Head and Neck Cancer

類似資料

• Synergistic inhibition of head and neck tumor growth by green tea (−)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor
  著者:: Zhang, Xin, 等
  出版事項: (2008)
• Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer
  著者:: Kirby, A M, 等
  出版事項: (2006)
• Sequence-dependent effects of ZD1839 (‘Iressa’) in combination with cytotoxic treatment in human head and neck cancer
  著者:: Magné, N, 等
  出版事項: (2002)
• Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil
  著者:: Magné, N, 等
  出版事項: (2003)
• Role of EGFR degradation in cisplatin-induced cytotoxicity in head and neck cancer
  著者:: Ahsan, A, 等
  出版事項: (2010)